Development of India’s Pharmaceutical Industry

Prabodh Malhotra

Chapter 4 in Impact of TRIPS in India, 2010, pp 57-79 from Palgrave Macmillan

Abstract: Abstract The development of India’s pharmaceutical industry has played a significant role in boosting the availability and affordability of pharmaceuticals. With significantly lower manufacturing costs relative to those in developed countries, Indian companies were able to lower the drug prices and increase access to medicines in India as well as in other low- and middle-income countries (LMICs). A number of policies introduced in the 1970s (discussed later in the chapter) underpinned this growth from a virtually non-existent pharmaceutical industry to becoming the world’s largest producer of generics.

Keywords: Foreign Direct Investment; Pharmaceutical Industry; Business Model; Indian Company; Sales Revenue (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-29074-7_4

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230290747

DOI: 10.1057/9780230290747_4

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().